Lista de obras -

Abdominal obesity contributes to neurocognitive impairment in HIV-infected patients with increased inflammation and immune activation

artículo científico publicado en 2015

Apolipoprotein E ε4 genotype status is not associated with neuroimaging outcomes in a large cohort of HIV+ individuals

artículo científico publicado en 2016

Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline

artículo científico publicado en 2014

Bacteriologically-confirmed pulmonary tuberculosis in an Ethiopian prison: Prevalence from screening of entrant and resident prisoners

artículo científico publicado en 2019

Brain mitochondrial injury in human immunodeficiency virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors

artículo científico publicado en 2005

CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy

artículo científico publicado en 2011

CSF biomarkers of monocyte activation and chemotaxis correlate with magnetic resonance spectroscopy metabolites during chronic HIV disease

artículo científico publicado en 2015

Cerebrospinal fluid cell-free mitochondrial DNA is associated with HIV replication, iron transport, and mild HIV-associated neurocognitive impairment

artículo científico publicado en 2017

Cerebrospinal fluid human immunodeficiency virus viral load in patients with neurosyphilis

artículo científico publicado en 2010

Clinical factors related to brain structure in HIV: the CHARTER study

artículo científico publicado en 2011

Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria

scientific article published on 18 April 2012

Clinical variables identify seronegative HCV co-infection in HIV-infected individuals

artículo científico publicado en 2011

Cognitive functioning during highly active antiretroviral therapy interruption in human immunodeficiency virus type 1 infection

artículo científico publicado en 2008

Correlation of in vivo neuroimaging abnormalities with postmortem human immunodeficiency virus encephalitis and dendritic loss

artículo científico publicado en 2004

Darunavir is predominantly unbound to protein in cerebrospinal fluid and concentrations exceed the wild-type HIV-1 median 90% inhibitory concentration

artículo científico publicado en 2012

Differences in Neurocognitive Impairment Among HIV-Infected Latinos in the United States

artículo científico publicado en 2017

Dynamics of monocyte chemoattractant protein type one (MCP-1) and HIV viral load in human cerebrospinal fluid and plasma

article

Efavirenz concentrations in CSF exceed IC50 for wild-type HIV ⬇️

artículo científico publicado el 23 de noviembre de 2010

Effects of traumatic brain injury on cognitive functioning and cerebral metabolites in HIV-infected individuals

artículo científico publicado en 2011

Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders

artículo científico publicado en 2004

Erratum to: Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria

article

Etravirine in CSF is highly protein bound

artículo científico publicado en 2013

Evaluating the accuracy of self-report for the diagnosis of HIV-associated neurocognitive disorder (HAND): defining "symptomatic" versus "asymptomatic" HAND.

artículo científico publicado en 2016

Family history of dementia predicts worse neuropsychological functioning among HIV-infected persons

artículo científico publicado en 2011

Genetic attributes of cerebrospinal fluid-derived HIV-1 env.

artículo científico publicado en 2006

Genetic features of cerebrospinal fluid-derived subtype B HIV-1 tat.

artículo científico publicado en 2012

Genetic variation in iron metabolism is associated with neuropathic pain and pain severity in HIV-infected patients on antiretroviral therapy

artículo científico publicado en 2014

Genome-wide association study of HIV-associated neurocognitive disorder (HAND): A CHARTER group study

artículo científico publicado en 2017

HIV infection and aging independently affect brain function as measured by functional magnetic resonance imaging

artículo científico publicado en 2010

HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients

artículo científico publicado en 2007

HIV-associated distal neuropathic pain is associated with smaller total cerebral cortical gray matter

artículo científico publicado en 2014

HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors ⬇️

artículo científico publicado el 21 de diciembre de 2010

Human immunodeficiency virus protease inhibitors and risk for peripheral neuropathy

artículo científico publicado en 2008

Increases in brain white matter abnormalities and subcortical gray matter are linked to CD4 recovery in HIV infection

artículo científico publicado en 2013

Latent Toxoplasma Infection and Higher Toxoplasma gondii Immunoglobulin G Levels Are Associated With Worse Neurocognitive Functioning in HIV-Infected Adults.

artículo científico publicado en 2016

Lifetime suicidal ideation and attempt are common among HIV+ individuals

artículo científico publicado en 2011

Low atazanavir concentrations in cerebrospinal fluid

artículo científico publicado en 2009

Low cerebrospinal fluid concentrations of the nucleotide HIV reverse transcriptase inhibitor, tenofovir

artículo científico publicado en 2012

Lower CSF Aβ is Associated with HAND in HIV-Infected Adults with a Family History of Dementia

artículo científico publicado en 2015

Lower than expected maraviroc concentrations in cerebrospinal fluid exceed the wild-type CC chemokine receptor 5-tropic HIV-1 50% inhibitory concentration

artículo científico publicado en 2012

Meeting practical challenges of a trial involving a multitude of treatment regimens: an example of a multi-center randomized controlled clinical trial in neuroAIDS.

artículo científico publicado en 2007

Mitochondrial DNA Haplogroups and Neurocognitive Impairment During HIV Infection

artículo científico publicado en 2015

Mitochondrial DNA variation and HIV-associated sensory neuropathy in CHARTER.

artículo científico publicado en 2012

Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study

artículo científico publicado en 2014

Neurocognitive functioning among HIV-positive adults in southern India

artículo científico publicado en 2017

Neurocognitive impact of substance use in HIV infection

artículo científico publicado en 2011

Normative data and validation of a regression based summary score for assessing meaningful neuropsychological change

artículo científico publicado en 2011

Patterns of selective neuronal damage in methamphetamine-user AIDS patients

artículo científico publicado en 2003

Population pharmacokinetics of abacavir in plasma and cerebrospinal fluid

artículo científico publicado en 2005

Prediction of incident neurocognitive impairment by plasma HIV RNA and CD4 levels early after HIV seroconversion

artículo científico publicado en 2003

Prevalence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy.

artículo científico publicado en 2016

Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA.

artículo científico publicado en 2002

Randomized trial of central nervous system-targeted antiretrovirals for HIV-associated neurocognitive disorder

artículo científico publicado en 2013

Relationship of CSF leukocytosis to compartmentalized changes in MCP-1/CCL2 in the CSF of HIV-infected patients undergoing interruption of antiretroviral therapy

article

Relationship of Medication Management Test-Revised (MMT-R) performance to neuropsychological functioning and antiretroviral adherence in adults with HIV.

artículo científico publicado en 2012

Relationship of antiretroviral treatment to postmortem brain tissue viral load in human immunodeficiency virus-infected patients

artículo científico publicado en 2006

Reply to Haddow et al.

artículo científico publicado en 2015

Role of metabolic syndrome components in HIV-associated sensory neuropathy

artículo científico publicado en 2009

Role of metabolic syndrome components in human immunodeficiency virus-associated stroke

artículo científico publicado en 2009

Severe, demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy

artículo científico publicado en 2002

The concomitant use of second-generation antipsychotics and long-term antiretroviral therapy may be associated with increased cardiovascular risk

artículo científico publicado en 2014

The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease

artículo científico publicado en 2005

The impact of HIV-associated neuropsychological impairment on everyday functioning

artículo científico publicado en 2004

The relationship between AIDS retinal cotton wool spots and neuropsychological impairment in HIV-positive individuals in the pre-highly active antiretroviral therapy era.

artículo científico publicado en 2004

The role of cohort studies in drug development: clinical evidence of antiviral activity of serotonin reuptake inhibitors and HMG-CoA reductase inhibitors in the central nervous system

artículo científico publicado en 2007

Therapeutic amprenavir concentrations in cerebrospinal fluid

artículo científico publicado en 2012

Total raltegravir concentrations in cerebrospinal fluid exceed the 50-percent inhibitory concentration for wild-type HIV-1.

artículo científico publicado en 2010

Two-year prospective study of major depressive disorder in HIV-infected men

artículo científico publicado en 2007

Use of Neuroimaging to Inform Optimal Neurocognitive Criteria for Detecting HIV-Associated Brain Abnormalities ⬇️

scientific article published on 02 October 2019

Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system

artículo científico publicado en 2008

White matter damage, neuroinflammation, and neuronal integrity in HAND

artículo científico publicado en 2018

Lista de obras de

Abdominal obesity contributes to neurocognitive impairment in HIV-infected patients with increased inflammation and immune activation

Apolipoprotein E ε4 genotype status is not associated with neuroimaging outcomes in a large cohort of HIV+ individuals

Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline

Bacteriologically-confirmed pulmonary tuberculosis in an Ethiopian prison: Prevalence from screening of entrant and resident prisoners

Brain mitochondrial injury in human immunodeficiency virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors

CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy

CSF biomarkers of monocyte activation and chemotaxis correlate with magnetic resonance spectroscopy metabolites during chronic HIV disease

Cerebrospinal fluid cell-free mitochondrial DNA is associated with HIV replication, iron transport, and mild HIV-associated neurocognitive impairment

Cerebrospinal fluid human immunodeficiency virus viral load in patients with neurosyphilis

Clinical factors related to brain structure in HIV: the CHARTER study

Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria

Clinical variables identify seronegative HCV co-infection in HIV-infected individuals

Cognitive functioning during highly active antiretroviral therapy interruption in human immunodeficiency virus type 1 infection

Correlation of in vivo neuroimaging abnormalities with postmortem human immunodeficiency virus encephalitis and dendritic loss

Darunavir is predominantly unbound to protein in cerebrospinal fluid and concentrations exceed the wild-type HIV-1 median 90% inhibitory concentration

Differences in Neurocognitive Impairment Among HIV-Infected Latinos in the United States

Dynamics of monocyte chemoattractant protein type one (MCP-1) and HIV viral load in human cerebrospinal fluid and plasma

Efavirenz concentrations in CSF exceed IC50 for wild-type HIV ⬇️

Effects of traumatic brain injury on cognitive functioning and cerebral metabolites in HIV-infected individuals

Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders

Erratum to: Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria

Etravirine in CSF is highly protein bound

Evaluating the accuracy of self-report for the diagnosis of HIV-associated neurocognitive disorder (HAND): defining "symptomatic" versus "asymptomatic" HAND.

Family history of dementia predicts worse neuropsychological functioning among HIV-infected persons

Genetic attributes of cerebrospinal fluid-derived HIV-1 env.

Genetic features of cerebrospinal fluid-derived subtype B HIV-1 tat.

Genetic variation in iron metabolism is associated with neuropathic pain and pain severity in HIV-infected patients on antiretroviral therapy

Genome-wide association study of HIV-associated neurocognitive disorder (HAND): A CHARTER group study

HIV infection and aging independently affect brain function as measured by functional magnetic resonance imaging

HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients

HIV-associated distal neuropathic pain is associated with smaller total cerebral cortical gray matter

HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors ⬇️

Human immunodeficiency virus protease inhibitors and risk for peripheral neuropathy

Increases in brain white matter abnormalities and subcortical gray matter are linked to CD4 recovery in HIV infection

Latent Toxoplasma Infection and Higher Toxoplasma gondii Immunoglobulin G Levels Are Associated With Worse Neurocognitive Functioning in HIV-Infected Adults.

Lifetime suicidal ideation and attempt are common among HIV+ individuals

Low atazanavir concentrations in cerebrospinal fluid

Low cerebrospinal fluid concentrations of the nucleotide HIV reverse transcriptase inhibitor, tenofovir

Lower CSF Aβ is Associated with HAND in HIV-Infected Adults with a Family History of Dementia

Lower than expected maraviroc concentrations in cerebrospinal fluid exceed the wild-type CC chemokine receptor 5-tropic HIV-1 50% inhibitory concentration

Meeting practical challenges of a trial involving a multitude of treatment regimens: an example of a multi-center randomized controlled clinical trial in neuroAIDS.

Mitochondrial DNA Haplogroups and Neurocognitive Impairment During HIV Infection

Mitochondrial DNA variation and HIV-associated sensory neuropathy in CHARTER.

Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study

Neurocognitive functioning among HIV-positive adults in southern India

Neurocognitive impact of substance use in HIV infection

Normative data and validation of a regression based summary score for assessing meaningful neuropsychological change

Patterns of selective neuronal damage in methamphetamine-user AIDS patients

Population pharmacokinetics of abacavir in plasma and cerebrospinal fluid

Prediction of incident neurocognitive impairment by plasma HIV RNA and CD4 levels early after HIV seroconversion

Prevalence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy.

Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA.

Randomized trial of central nervous system-targeted antiretrovirals for HIV-associated neurocognitive disorder

Relationship of CSF leukocytosis to compartmentalized changes in MCP-1/CCL2 in the CSF of HIV-infected patients undergoing interruption of antiretroviral therapy

Relationship of Medication Management Test-Revised (MMT-R) performance to neuropsychological functioning and antiretroviral adherence in adults with HIV.

Relationship of antiretroviral treatment to postmortem brain tissue viral load in human immunodeficiency virus-infected patients

Reply to Haddow et al.

Role of metabolic syndrome components in HIV-associated sensory neuropathy

Role of metabolic syndrome components in human immunodeficiency virus-associated stroke

Severe, demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy

The concomitant use of second-generation antipsychotics and long-term antiretroviral therapy may be associated with increased cardiovascular risk

The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease

The impact of HIV-associated neuropsychological impairment on everyday functioning

The relationship between AIDS retinal cotton wool spots and neuropsychological impairment in HIV-positive individuals in the pre-highly active antiretroviral therapy era.

The role of cohort studies in drug development: clinical evidence of antiviral activity of serotonin reuptake inhibitors and HMG-CoA reductase inhibitors in the central nervous system

Therapeutic amprenavir concentrations in cerebrospinal fluid

Total raltegravir concentrations in cerebrospinal fluid exceed the 50-percent inhibitory concentration for wild-type HIV-1.

Two-year prospective study of major depressive disorder in HIV-infected men

Use of Neuroimaging to Inform Optimal Neurocognitive Criteria for Detecting HIV-Associated Brain Abnormalities ⬇️

Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system

White matter damage, neuroinflammation, and neuronal integrity in HAND